<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02559765</url>
  </required_header>
  <id_info>
    <org_study_id>200140102</org_study_id>
    <nct_id>NCT02559765</nct_id>
  </id_info>
  <brief_title>Access, Use and Opinions of Physiotherapy and Rehabilitation Services of People With Progressive MS in the UK.</brief_title>
  <official_title>Current Access to, Use and Perceived Efficacy of Physiotherapy and Rehabilitation Services by People With Progressive Multiple Sclerosis: a Survey of People With Progressive Multiple Sclerosis Via the UK MS Register.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NHS Ayrshire &amp; Arran</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>AKM Stats</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Glasgow</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This survey will investigate the views of people with progressive MS in terms of
      physiotherapy services. In particular the study will examine the proportion of people with
      progressive MS on the MS register who use physiotherapy services, how worthwhile they think
      it is for them and how they would like their physiotherapy to be delivered. This survey will
      also explore how physiotherapy services for people with progressive MS varies across the UK
      and what other types of rehabilitation services are currently used by people with progressive
      MS.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Multiple Sclerosis has three main forms: Relapsing Remitting MS (RRMS), Primary Progressive
      MS (PPMS) and Secondary Progressive MS (SPMS) as well as a rarer form called Progressive
      Relapsing MS (PRMS).

      In cases of RRMS an individual will have periods of worsened symptoms followed by periods of
      remission. During remission the individual may make a full recovery or be left with some
      residual impairment. In both PPMS and SPMS an individual will have continuous worsening
      symptoms with a gradual increase in disability with little or no transient recovery. An
      individual with PRMS will have the continuous worsening of disability seen in both PPMS and
      SPMS coupled with occasional relapses as seen in RRMS.

      Currently 15% of those with MS are diagnosed as PPMS, 5% are diagnosed with the rarer form of
      PRMS and approximately 80% are diagnosed with RRMS. However, approximately 65% of those with
      RRMS will go on to develop SPMS. This means that approximately 72% of all individuals with MS
      will be in a progressive phase of the disease at some point in their life.

      Whilst there are disease modifying drugs available for those with RRMS there are currently
      limited pharmacological treatments available for those with the progressive forms of the
      disease. Physiotherapy and rehabilitation services are often used by people with progressive
      MS and access to these are part of the current NICE guidelines for the management of MS.
      Whilst physiotherapy and rehabilitation services are used by people with progressive MS there
      is currently no research investigating how many people with progressive MS use these
      services, who provides them, how they are delivered, how effective the recipient feels the
      treatment is and how they would like their service to be delivered. In addition the
      Progressive MS Alliance has highlighted progressive MS and symptom management and
      rehabilitation as an under-researched area.

      The UK MS Register is funded by the MS Society and operated by the health informatics
      department within the College of Medicine at Swansea University. People with MS can sign up
      to the register and answer pre-set questionnaires online. The purpose of the Register is to
      be a longitudinal research database collecting routine data every three months as well as
      conducting individually commissioned cross sectional studies. It currently has over 11,000
      members and over 2,200 of those registrants have a progressive form of MS. Not only is this
      is the first study with the UK MS register to focus on people with progressive forms of MS
      but also the first to focus on physiotherapy services.

      This is a unique opportunity to access this patient group across a large geographical region
      and gain an insight into how physiotherapy and rehabilitation services are used, delivered
      and perceived. The outcome of this research has the potential to inform future physiotherapy
      interventions and rehabilitation guidelines.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2015</start_date>
  <completion_date type="Actual">November 2015</completion_date>
  <primary_completion_date type="Actual">November 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants with access to physiotherapy for their MS. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Questionnaire has the following options: yes, no. Participant may choose one.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants that use physiotherapy for their MS. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Questionnaire has the following options: yes, no. Participant may choose one.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>What is the participants' perceived efficacy of physiotherapy for their MS? Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Nominal scale of: very harmful, harmful, neither harmful nor beneficial, beneficial, very beneficial Participant may choose one.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Most common referral process. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose more than one: Neurologist; GP; self-referral; MS nurse; other (please state); don't know</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common provider of physiotherapy to the participant. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose more than one: NHS; private (self funded); private (insurance); charity; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common physiotherapy intervention received for participant's MS. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose more than one: exercises to do at home prescribed by a physiotherapist; exercises with a physiotherapist; functional electrical stimulation, transcutaneous electrical stimulation; tilt table; acupuncture; advice or education from a physiotherapist; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common pattern of physiotherapy appointments. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose only one: receiving physiotherapy sessions regularly; pattern varies depending on symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common expected waiting time from referral to receiving physiotherapy appointment. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: less than a week; 1 to 2 weeks; 2 or more weeks but less than 4 weeks; 4 or more weeks but less than 6 weeks; 6 or more weeks but less than 12 weeks; 12 or more weeks.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common frequency of appointments. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: once or more a week; once a fortnight; once every 1 to 3 months; twice a year; once a year or less</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common length of physiotherapy sessions. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: up to half an hour; between half an hour and an hour; more than an hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common number of people present at physiotherapy sessions. Questionnaire.</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose more than one: one to one; 2- 4 people, 5 or more people; over the phone or internet.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common setting of receipt of physiotherapy. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose more than one: at home; in a hospital or clinic; in a community centre; in a charity centre; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who think they need more physiotherapy than they currently receive. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: yes; no; don't know</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common desired pattern of delivery of physiotherapy. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: regularly; to vary depending on symptoms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common desired frequency of appointments. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose only one: once or more a week; once a fortnight; once every 1 to 3 months; twice a year; once a year or less</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common desired length of physiotherapy appointments. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose one: up to half an hour; between half an hour and an hour; more than an hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common desired setting for receiving physiotherapy. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose one: at home; in a hospital or clinic; in a community centre; in a charity centre; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common desired number of people present at physiotherapy sessions. Questionnaire.</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose one: one to one; 2- 4 people, 5 or more people; over the phone or internet.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common barriers to receiving physiotherapy. Questionnaire.</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose form the following options and choose more than one then rate their most severe from 1-3: Pain; fear of falling; bladder or bowels problems; fatigue; depression; anxiety/panic attacks; difficulty with walking; difficulty with wheelchair transfers; transport problems; distance to travel; lack of suitable parking; lack of time; family commitments; work commitments; cost; need someone to come with me; personal issues with physiotherapist; problems being referred to physiotherapy; physiotherapy is not available; physiotherapy will not be beneficial for me; there is nothing that makes it difficult for me to receive physiotherapy; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who have access to MS specialist services. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: yes; no.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who are able to access MS specialist services as their needs change. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: yes; no.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common health professional available as part of MS specialist services. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose more than one: Occupational therapist; Social worker; MS specialist nurse; Continence nurse; Nurse: other (please state); Psychologist; GP; MS specialist Doctor/Neurologist; Doctor: other (please state); Speech and language therapist; Dietician; Orthotist; Other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most commonly used health professional available as part of MS specialist services. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose more than one: Occupational therapist; Social worker; MS specialist nurse; Continence nurse; Nurse: other (please state); Psychologist; GP; MS specialist Doctor/Neurologist; Doctor: other (please state); Speech and language therapist; Dietician; Orthotist; Other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants who are offered a regular review for their MS. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: yes; no; don't know</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common frequency of review. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: twice a year; once a year; less than once a year; don't know.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common health professional who carries out review. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: MS specialist Doctor/Neurologist; GP; Nurse; Physiotherapist; Occupational therapist; The person who does my review can vary; Other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common setting of review. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: at home; in a hospital or clinic; in a community centre; GP surgery; other (please state)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common disease modifying therapy taken in past. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: Beta-interferon (Rebif, Avonex, Betaferon); Glatiramer acetate (Copaxone); Dimethyl fumarate (Tecfidera); Teriflunomide (Aubagio); Natalizumab (Tysabri, Antigren); Fingolimod (Gilenya, Novartis); Mitoxantrone (novantrone); Alemtuzumab (Lemtrada); I have never taken any of these medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most common disease modifying therapy being taken. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose one: Beta-interferon (Rebif, Avonex, Betaferon); Glatiramer acetate (Copaxone); Dimethyl fumarate (Tecfidera); Teriflunomide (Aubagio); Natalizumab (Tysabri, Antigren); Fingolimod (Gilenya, Novartis); Mitoxantrone (novantrone); Alemtuzumab (Lemtrada); â€¢ I do not currently take any of these medications</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Most commonly used complimentary therapy used for MS. Questionnaire</measure>
    <time_frame>three months</time_frame>
    <description>Participant may choose from the following options and choose more than one: Massage; Reflexology; Osteopathy or chiropractic; Magnet field therapy; The Alexander technique; Acupuncture or acupressure; Hyperbaric oxygen therapy; Reiki; Aromatherapy Relaxation or meditation; Homeopathy or herbal medicine; Other (please state)</description>
  </secondary_outcome>
  <enrollment type="Actual">1298</enrollment>
  <condition>Progressive Multiple Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        People with progressive multiple sclerosis and registered on the UK MS Register
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Have a form of progressive MS

          -  Be registered on the UK MS Register

        Exclusion Criteria:

          -  Have relapsing remitting MS

          -  Be under 18 years of age
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evan Campbell, MRes</last_name>
    <role>Principal Investigator</role>
    <affiliation>The University of Glasgow</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The University of Glasgow</name>
      <address>
        <city>Glasgow</city>
        <zip>G12 8LL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 21, 2015</study_first_submitted>
  <study_first_submitted_qc>September 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 24, 2015</study_first_posted>
  <last_update_submitted>May 11, 2016</last_update_submitted>
  <last_update_submitted_qc>May 11, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 13, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Glasgow</investigator_affiliation>
    <investigator_full_name>Evan Campbell</investigator_full_name>
    <investigator_title>Research physiotherapist</investigator_title>
  </responsible_party>
  <keyword>physiotherapy</keyword>
  <keyword>progressive multiple sclerosis</keyword>
  <keyword>rehabilitation</keyword>
  <keyword>rehabilitation services</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Multiple Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

